Royalty Pharma

NASDAQ: RPRX · Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
1.6B 1.77B 1.33B 1.71B 1.03B 1.19B 1.7B 372.47M 470.81M 611.07M 230.06M 893.76M 895.15M 1.21B 1.24B 1.55B 1.96B 1.75B
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.67M 11.47M 17.26M 23M 23M 23M 23M 23M
Stock-Based Compensation
1.05M 2.25M 2.34M 2.44M 2.49M 2.4M 2.36M 2.32M 2.32M 2.25M 2.17M 2.09M 2.01M 2.23M 2.44M 2.78M 3.12M 6.14M
Other Working Capital
743.67M 8.55M 60.22M 42.84M 29.31M 13.18M -1.45M -8.6M -5.89M 1.23M -1.34M 7.05M 9.39M 4.09M 17.41M 19.41M 51.32M 2.15M
Other Non-Cash Items
118.77M 911.26M 1.38B 1.03B 1.61B 1.41B 1.28B 2.43B 2.29B 2.07B 1.87B 1.1B 1.06B 739.24M 767.22M 544.96M 123.21M 316.36M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
744.54M 18.4M 53.38M 49.77M 31.48M 19.02M 5.38M -17.58M -11.54M 29.24M 32.66M 53.75M 21.77M -23.06M -16.32M -31.64M 26.4M -7.71M
Operating Cash Flow
2.47B 2.7B 2.77B 2.8B 2.67B 2.62B 2.99B 2.79B 2.75B 2.72B 2.14B 2.06B 1.99B 1.95B 2.02B 2.09B 2.13B 2.09B
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
-69.37M -3.98M -10.96M -12.95M -16.93M -15.93M -12.54M -10.55M -13.41M -10.43M -9.9M -16.43M -20.48M -29.19M -34.85M -39.21M -28.32M -35.73M
Purchase of Investments
-1.78B -2.66B -2.74B -3.24B -2.49B -1.6B -2.12B -1.47B -2.65B -2.89B -2.57B -2.87B -2.72B -2.84B -3.59B -4.34B -4.06B -4.11B
Sales Maturities Of Investments
541.49M 640.06M 118.36M 107.22M 104.33M 2.88M 25.83M 800.2M 1.01B 1.28B 1.55B 890.08M 1.32B 1.63B 1.78B 2.25B 1.88B 1.53B
Other Investing Acitivies
-251.55M -68.02M -49.32M -24.95M -31.98M 12.04M 29.44M 26.82M 22.37M 22.37M n/a n/a n/a -18.08M -18.08M -18.08M -18.08M 15.08M
Investing Cash Flow
-1.56B -2.09B -2.68B -3.17B -2.43B -1.6B -2.07B -657.88M -1.63B -1.6B -1.03B -2B -1.42B -1.26B -1.87B -2.15B -2.23B -2.6B
Debt Repayment
n/a n/a n/a n/a -1B -1B -1B -1B n/a n/a n/a n/a 1.27B 1.27B 1.27B 1.27B -94.77M -141.87M
Common Stock Repurchased
-1.15B -938.43M -229.65M -207.24M -250.32M -170.32M -170.32M -140.12M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-376.31M -378.02M -376.46M -372.15M -367.84M -363.5M -358.33M -353.19M -347.25M -339.69M -333.32M -322.72M -311.93M -301.46M -285.18M -269.19M -251.05M -322.05M
Other Financial Acitivies
-511.08M 948.29M 967.26M 966.61M 971.38M -616.56M -620.11M -689.1M -705.76M -594.57M -611.53M -554.65M -573.62M -580.25M -602.24M -696.65M -730.56M -726.85M
Financial Cash Flow
-2.04B -368.16M 361.14M 387.21M -646.77M -2.15B -2.15B -2.18B -1.05B -934.26M -944.86M -877.38M 386.98M 390.82M 385.11M 305.79M -1.09B 717.98M
Net Cash Flow
-1.13B 244.72M 452.02M 13.6M -408.43M -1.13B -1.23B -55.18M 65.04M 184.17M 169.7M -809.18M 965.76M 1.08B 532.37M 248.01M -1.18B 210.74M
Free Cash Flow
2.47B 2.7B 2.77B 2.8B 2.67B 2.62B 2.99B 2.79B 2.75B 2.72B 2.14B 2.06B 1.99B 1.95B 2.02B 2.09B 2.13B 2.09B